Innovations in Laboratory Testing for Decentralized Clinical Trials and Optimizations for Future

The landscape of clinical trials is undergoing a paradigm shift with the advent of decentralized clinical trials. In this webinar, the speakers will explore the emerging trends and future directions in decentralized clinical trials, focusing on how a large global central clinical laboratory supports decentralized lab sampling and medical laboratory testing for these trials.

Decentralized clinical trials offer a promising solution to many of the challenges faced by traditional clinical trials. By leveraging technology and innovative approaches, decentralized clinical trials aim to enhance patient recruitment, retention and engagement while reducing geographical and logistical barriers.

The speakers will discuss how the central laboratory is supporting medical laboratory testing in a decentralized setting. This includes the implementation of logistics for the direct-to-patient shipment of clinical trial supplies, patient specific sample collection kits, direct-from-patient shipment of samples to the central lab and collection of clinical trial samples at patient service centers.

They will also explore the latest developments in micro-sampling technologies, which allow for the collection of small blood volumes with minimal discomfort, and their implications for the future of clinical trials. These innovations empower patients to collect samples at home, reducing the need for frequent visits to clinical sites, reducing discomfort and inconvenience. Attendees will also gain valuable insights into the pivotal role of clinical laboratories in decentralized clinical trial designs.

Join this webinar to explore how decentralized clinical trials are shaping the future of clinical research and how the central laboratory is innovating patient-centric approaches for better patient outcomes and more efficient trials.

Speakers

Angela Tucker, Program Director, Decentralized Clinical Trials, Labcorp

Angela Tucker currently serves as Program Director for Decentralized Trials at Labcorp Central Laboratory Services and has over 29 years of experience in clinical trials at Labcorp. In her previous role, she served as Senior Director, Global Project Management, leading the client delivery teams in US and Europe.

She began her career as a Medical Technologist but later transitioned into Project Management where she spent the vast majority of her Labcorp career. She also held leadership roles in operations leading several investigator support departments focused on improving the services for investigator sites and with business systems developing systems focused on improving operational delivery. She holds a BS in Medical Technology from Austin Peay State University.

Message Presenter

Nadia Ayala-Lopez, PhD, Director Clinical Chemistry, Medical Affairs, Central Laboratory Services and Clinical Laboratory Director, Labcorp

Dr. Ayala-Lopez is Director of Clinical Chemistry in Medical Affairs at Labcorp Drug Development where she provides medical, scientific and regulatory support for the Central Laboratory Services in the areas of hematology, clinical chemistry, special chemistry, analytical chemistry and toxicology. She also serves as the Medical Laboratory Director for Labcorp Bioanalytical Services in Indianapolis, Indiana.

She completed a fellowship in clinical chemistry at Johns Hopkins University School of Medicine and Vanderbilt University Medical Center. Additionally, she completed a National Institutes of Health (NIH)-supported research fellowship at the Yale University School of Medicine in the Department of Laboratory Medicine. She earned a PhD in Pharmacology and Toxicology from Michigan State University where she was awarded an NIH Individual Training Grant for her research on the adrenergic system of perivascular adipose tissue.

Read more...

She is board-certified in Clinical Chemistry by the American Board of Clinical Chemistry, is a certified Clinical Chemist by the National Registry of Certified Chemists and holds a board certification as a Medical Laboratory Scientist by the American Society for Clinical Pathology.

She has over 30 publications spanning the topics of laboratory medicine, clinical toxicology and adrenergic pharmacology. She has received research and presentation awards from the Academy of Clinical Physicians and Scientists (ACLPS), American Society for Clinical Lab Sciences (ASCLS), American Association for Clinical Chemistry (AACC), American Heart Association (AHA) Council on Hypertension and the American Society for Experimental Therapeutics (ASPET).

Her contributions to the medical laboratory profession include numerous activities supporting the professional development and mentoring of laboratory professionals and supporting diversity, equity and inclusion in laboratory medicine.

Read Less...

Message Presenter